These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 12189723)
1. Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals. Volkin DB; Sanyal G; Burke CJ; Middaugh CR Pharm Biotechnol; 2002; 14():1-46. PubMed ID: 12189723 [No Abstract] [Full Text] [Related]
2. Aseptic processing of protein pharmaceuticals. Townsend M Pharm Biotechnol; 2002; 14():129-89. PubMed ID: 12189724 [No Abstract] [Full Text] [Related]
3. The stability factor: importance in formulation development. Krishnamurthy R; Manning MC Curr Pharm Biotechnol; 2002 Dec; 3(4):361-71. PubMed ID: 12463418 [TBL] [Abstract][Full Text] [Related]
4. Getting to the core of protein pharmaceuticals--Comprehensive structure analysis by mass spectrometry. Leurs U; Mistarz UH; Rand KD Eur J Pharm Biopharm; 2015 Jun; 93():95-109. PubMed ID: 25791210 [TBL] [Abstract][Full Text] [Related]
5. Predictive Screening Tools Used in High-Concentration Protein Formulation Development. Hofmann M; Gieseler H J Pharm Sci; 2018 Mar; 107(3):772-777. PubMed ID: 29102552 [TBL] [Abstract][Full Text] [Related]
6. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients. Jorgensen L; Hostrup S; Moeller EH; Grohganz H Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792 [TBL] [Abstract][Full Text] [Related]
7. Protein formulation and fill-finish operations. Patro SY; Freund E; Chang BS Biotechnol Annu Rev; 2002; 8():55-84. PubMed ID: 12436915 [TBL] [Abstract][Full Text] [Related]
8. Overview of drug product development. Narayan P Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349 [TBL] [Abstract][Full Text] [Related]
9. Antibody structure, instability, and formulation. Wang W; Singh S; Zeng DL; King K; Nema S J Pharm Sci; 2007 Jan; 96(1):1-26. PubMed ID: 16998873 [TBL] [Abstract][Full Text] [Related]
10. Formulation development and stability testing of oral morphine solution utilizing preformulation approach. Preechagoon D; Sumyai V; Tontisirin K; Aumpon S; Pongjanyakul T J Pharm Pharm Sci; 2005 Aug; 8(2):362-9. PubMed ID: 16124948 [TBL] [Abstract][Full Text] [Related]
11. High throughput formulation: strategies for rapid development of stable protein products. Nayar R; Manning MC Pharm Biotechnol; 2002; 13():177-98. PubMed ID: 11987752 [No Abstract] [Full Text] [Related]
15. Challenges for the pharmaceutical technical development of protein coformulations. Mueller C; Altenburger U; Mohl S J Pharm Pharmacol; 2018 May; 70(5):666-674. PubMed ID: 28470967 [TBL] [Abstract][Full Text] [Related]
16. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques. Chadha R; Bhandari S J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418 [TBL] [Abstract][Full Text] [Related]
18. Challenges in the development of high protein concentration formulations. Shire SJ; Shahrokh Z; Liu J J Pharm Sci; 2004 Jun; 93(6):1390-402. PubMed ID: 15124199 [TBL] [Abstract][Full Text] [Related]